Diffusion-Weighted Imaging of Breast Cancer: Correlation of the Apparent Diffusion Coefficient Value with Pathologic Prognostic Factors
dc.contributor.author | Tezcan, Sehnaz | |
dc.contributor.author | Uslu, Nihal | |
dc.contributor.author | Ozturk, Funda Ulu | |
dc.contributor.author | Akcay, Eda Yilmaz | |
dc.contributor.author | Tezcaner, Tugan | |
dc.contributor.pubmedID | 31620686 | en_US |
dc.contributor.researcherID | ABC-5258-2020 | en_US |
dc.date.accessioned | 2020-11-04T11:22:01Z | |
dc.date.available | 2020-11-04T11:22:01Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Objective: The aim was to evaluate relationship between apparent diffusion coefficient (ADC) values with pathologic prognostic factors in breast carcinoma (BC). Materials and Methods: 83 patients were enrolled in this study. Prognostic factors included age, tumor size, expression of estrogen receptor (ER) and progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), nuclear grade (NG), lymph node involvement and histologic type. The relationship between ADC and prognostic factors was determined using Independent sample t-test, ANOVA, Pearson correlation and relative operating characteristics (ROC) analysis. Results: There was no significant difference between ADC and prognostic factors, including age, tumor size, ER, HER2 and histologic type. The PR-positive tumors (p=0.03) and axillary lymph node involvement (p=0.000) showed a significant association with lower ADC values. The ADC values were significantly lower in high-grade tumors than low-grade tumors (p=0.000). ROC analysis showed an optimal ADC threshold of 0.66 (x10-3 mm(2)/s) for differentiating low-grade tumors from high-grade tumors (sensitivity, 85.5%; specificity, 81%; area under curve, 0.90). Conclusion: The lower ADC values of BC were significantly associated with positive expression of PR, LN positivity and high-grade tumor. Especially, ADC values were valuable in predicting NG subgroups. | en_US |
dc.identifier.eissn | 2587-0831 | en_US |
dc.identifier.endpage | 267 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 262 | en_US |
dc.identifier.uri | https://www.eurjbreasthealth.com/Content/files/Cover%20and%20Front%20Matter(2).pdf | |
dc.identifier.uri | http://hdl.handle.net/11727/5000 | |
dc.identifier.volume | 15 | en_US |
dc.identifier.wos | 000488785600010 | en_US |
dc.language.iso | eng | en_US |
dc.relation.isversionof | 10.5152/ejbh.2019.4860 | en_US |
dc.relation.journal | EUROPEAN JOURNAL OF BREAST HEALTH | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Breast cancer | en_US |
dc.subject | diffusion-weighted imaging | en_US |
dc.subject | apparent diffusion coefficient | en_US |
dc.subject | factors | en_US |
dc.title | Diffusion-Weighted Imaging of Breast Cancer: Correlation of the Apparent Diffusion Coefficient Value with Pathologic Prognostic Factors | en_US |
dc.type | article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Cover and Front Matter(2).pdf
- Size:
- 606.46 KB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: